News | SPECT Imaging | September 23, 2015

Breakthrough SPECT Technology Wins Commercial Innovation of the Year at WMIC 2015

Show attendees award new imaging system with higher resolution, sensitivity than traditional SPECT

WMIS, WMIC 2015, MILabs, G-SPECT, Commerical Innovation of the Year, SPECT, PET, molecular imaging

G-SPECT photo courtesy of MILabs Inc.

September 23, 2015 — The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the 2015 World Molecular Imaging Congress (WMIC) to Frederik Beekman, CEO/CSO, MILabs for his work developing G-SPECT.   

The award winner was chosen based on votes from WMIC attendees for the unique clinical single-photon emission computed tomography (SPECT) platform that allows for < 3mm resolution, low-dose studies and imaging of fast tracer dynamics. Beekman and his team began work on G-SPECT in 2006, with hopes to translate their proprietary microSPECT technologies into a clinical machine. Given the current field-of-view available for this system and its unique potential for fast dynamic imaging, first applications are expected in brain, bone and pediatric imaging. A large field-of-view option for G-SPECT is already under development.

SPECT and positron emission tomography (PET) are two of the most important molecular imaging modalities in use for diagnosis and therapy follow-up. Today, SPECT imaging is applied to millions of patients each year. Although SPECT is a very useful tool, current resolution of typically 7-10 mm can limit diagnostic precision. MILabs has shown that this can be changed: The new G-SPECT has high sensitivity and far superior resolution compared to current clinical SPECT systems and has fast dynamic imaging capabilities.

WMIS asked members of the industry to submit abstracts for this award and six semi-finalists were chosen to present their innovation at WMIC. Semi-finalists were given three minutes to present, then the audience was given the opportunity to vote on the innovation of their choice. The six semi-finalists were selected from 28 submissions following a scientific review by unbiased reviewers. 

Two other innovations recognized as finalists for the 2015 Commercial Innovation of the Year Award:

  • Jeff Harford of LI-COR was selected as first runner-up for his abstract titled, "Targeted Photodestruction of Tumors Using Bioconjugates of Near-Infrared IRDye 700DX."
  • The second runner-up was Christian Wiest of iThera for his abstract titled, "The world's first tomographic hybrid OPtoacoustic/UltraSound imaging technology."

For more information: www.milabs.com

Related Content

PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
Novel PET Imaging Method Could Track and Guide Type 1 Diabetes Therapy
News | PET Imaging | August 03, 2018
Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The...
Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Overlay Init